Shigeki Nanjo

Also affiliated with Kanazawa University Hospital

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance”.

The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

Nature Genetics(2023)10.1038/s41588-023-01592-8

N/A

1.9DataRank · unranked

88 citations

Philippe Gui, Manasi K. Mayekar, Emily K. Law, Oriol Pich, Chris Bailey +80 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer

Journal of Clinical Investigation(2022)10.1172/jci145099

N/A

1.8DataRank · unranked

59 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Yu‐Ting Chou +23 more

Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer

Nature Communications(2024)10.1038/s41467-024-47423-0

N/A

1.7DataRank · unranked

93 citations

Yu‐Ting Chou, Lauren Čech, Celia Fernández-Méndez, Johnny Yu, Victor Olivas +30 more

Targeted cancer therapy induces APOBEC fuelling the evolution of drug resistance

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.18.423280

N/A

0.449DataRank · unranked

19 citations

Deborah R. Caswell, Natalie I. Vokes, Emily K. Law, Wei Wu, William Hill +43 more

A focal adhesion kinase-YAP signaling axis drives drug tolerant persister cells and residual disease in lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.23.465573

N/A

0.442DataRank · unranked

18 citations

Celia Fernández-Méndez, Lauren Čech, Johnny Yu, Ismail M. Meraz, Victor Olivas +28 more

Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.06.007

N/A

0.354DataRank · unranked

9 citations

Shigeki Nanjo, Shinji Takeuchi, Turja Chakrabarti, Tyiesha Brown, Sharon Wesley Dev Sahadevan +11 more

Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis

npj Precision Oncology(2024)10.1038/s41698-024-00582-1

N/A

0.330DataRank · unranked

8 citations

Shigeki Nanjo, Michael C. Jin, Jacob J. Chabon, David M. Kurtz, Aadel A. Chaudhuri +22 more

Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts

Science(2021)10.1126/science.abc1944

N/A

0DataRank · unranked

322 citations

Matthew G. Jones, Ross A. Okimoto, Shigeki Nanjo, Michelle M. Chan, Nir Yosef +3 more

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR mutant lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.26.356352

N/A

0DataRank · unranked

1 citations

Wei Wu, Niki Karachaliou, Collin M. Blakely, Junji Suzuki, Siraj M. Ali +14 more

Quantification of Cerebrospinal Fluid Tumor DNA in Lung Cancer Patients with Suspected Leptomeningeal Carcinomatosis

medRxiv(2024)10.1101/2024.01.03.23300646

N/A

0DataRank · unranked

0 citations

Shigeki Nanjo, Michael C. Jin, Jacob J. Chabon, David M. Kurtz, Aadel A. Chaudhuri +22 more

Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.16.045245

N/A

0DataRank · unranked

39 citations

Matthew G. Jones, Ross A. Okimoto, Shigeki Nanjo, Michelle M. Chan, Nir Yosef +3 more